Mammaglobin-A, VEGFR3, and Ki67 in Human Breast Cancer Pathology and Five Year Survival

Background/Methods: This study determines the co-expression of mammaglobin-A, vascular endothelial growth factor receptor-3 (VEGFR3) and Ki67 by immunohistochemistry (IHC) in tissue samples from 80 patients undergoing breast surgery (cancer or benign disease). The tissue expression was compared with...

Full description

Bibliographic Details
Main Authors: Elizabeth Baker, Naomi Whiteoak, Louise Hall, James France, Deborah Wilson, Pudupalayam Bhaskar
Format: Article
Language:English
Published: SAGE Publishing 2019-06-01
Series:Breast Cancer: Basic and Clinical Research
Online Access:https://doi.org/10.1177/1178223419858957
_version_ 1819008653732085760
author Elizabeth Baker
Naomi Whiteoak
Louise Hall
James France
Deborah Wilson
Pudupalayam Bhaskar
author_facet Elizabeth Baker
Naomi Whiteoak
Louise Hall
James France
Deborah Wilson
Pudupalayam Bhaskar
author_sort Elizabeth Baker
collection DOAJ
description Background/Methods: This study determines the co-expression of mammaglobin-A, vascular endothelial growth factor receptor-3 (VEGFR3) and Ki67 by immunohistochemistry (IHC) in tissue samples from 80 patients undergoing breast surgery (cancer or benign disease). The tissue expression was compared with the tumour histopathology and Kaplan Meier 5-year survival analysis was performed. Results: Positive breast tissue expression was observed in 53% samples for mammaglobin, 41% Ki67 and 65% VEGFR3 with a significant positive correlation between Ki67 and VEGFR3 co-expression. Ki67 and VEGFR3 expression correlated with the breast tumour grade and Ki67 expression also correlated with oestrogen receptor (ER) status. At 5 years post-operatively, 6/80 patients had died and 3 patients were alive but had cancer recurrence. High Ki67 expression significantly correlated with poor survival (disease-free and overall). Conclusions: In this study, VEGFR3 and Ki67 expression but not mammaglobin-A correlated with breast tumour pathology. Positive Ki67 expression was also associated with a poor 5-year survival outcome.
first_indexed 2024-12-21T00:43:54Z
format Article
id doaj.art-8b0895052f6646ed9d62a9bcde01a902
institution Directory Open Access Journal
issn 1178-2234
language English
last_indexed 2024-12-21T00:43:54Z
publishDate 2019-06-01
publisher SAGE Publishing
record_format Article
series Breast Cancer: Basic and Clinical Research
spelling doaj.art-8b0895052f6646ed9d62a9bcde01a9022022-12-21T19:21:35ZengSAGE PublishingBreast Cancer: Basic and Clinical Research1178-22342019-06-011310.1177/1178223419858957Mammaglobin-A, VEGFR3, and Ki67 in Human Breast Cancer Pathology and Five Year SurvivalElizabeth Baker0Naomi Whiteoak1Louise Hall2James France3Deborah Wilson4Pudupalayam Bhaskar5Department of Surgery, University Hospital of North Tees, Stockton on Tees, UKDepartment of Histopathology, University Hospital of North Tees, Stockton on Tees, UKDepartment of Histopathology, University Hospital of North Tees, Stockton on Tees, UKDepartment of Histopathology, University Hospital of North Tees, Stockton on Tees, UKDepartment of Surgery, University Hospital of North Tees, Stockton on Tees, UKDepartment of Surgery, University Hospital of North Tees, Stockton on Tees, UKBackground/Methods: This study determines the co-expression of mammaglobin-A, vascular endothelial growth factor receptor-3 (VEGFR3) and Ki67 by immunohistochemistry (IHC) in tissue samples from 80 patients undergoing breast surgery (cancer or benign disease). The tissue expression was compared with the tumour histopathology and Kaplan Meier 5-year survival analysis was performed. Results: Positive breast tissue expression was observed in 53% samples for mammaglobin, 41% Ki67 and 65% VEGFR3 with a significant positive correlation between Ki67 and VEGFR3 co-expression. Ki67 and VEGFR3 expression correlated with the breast tumour grade and Ki67 expression also correlated with oestrogen receptor (ER) status. At 5 years post-operatively, 6/80 patients had died and 3 patients were alive but had cancer recurrence. High Ki67 expression significantly correlated with poor survival (disease-free and overall). Conclusions: In this study, VEGFR3 and Ki67 expression but not mammaglobin-A correlated with breast tumour pathology. Positive Ki67 expression was also associated with a poor 5-year survival outcome.https://doi.org/10.1177/1178223419858957
spellingShingle Elizabeth Baker
Naomi Whiteoak
Louise Hall
James France
Deborah Wilson
Pudupalayam Bhaskar
Mammaglobin-A, VEGFR3, and Ki67 in Human Breast Cancer Pathology and Five Year Survival
Breast Cancer: Basic and Clinical Research
title Mammaglobin-A, VEGFR3, and Ki67 in Human Breast Cancer Pathology and Five Year Survival
title_full Mammaglobin-A, VEGFR3, and Ki67 in Human Breast Cancer Pathology and Five Year Survival
title_fullStr Mammaglobin-A, VEGFR3, and Ki67 in Human Breast Cancer Pathology and Five Year Survival
title_full_unstemmed Mammaglobin-A, VEGFR3, and Ki67 in Human Breast Cancer Pathology and Five Year Survival
title_short Mammaglobin-A, VEGFR3, and Ki67 in Human Breast Cancer Pathology and Five Year Survival
title_sort mammaglobin a vegfr3 and ki67 in human breast cancer pathology and five year survival
url https://doi.org/10.1177/1178223419858957
work_keys_str_mv AT elizabethbaker mammaglobinavegfr3andki67inhumanbreastcancerpathologyandfiveyearsurvival
AT naomiwhiteoak mammaglobinavegfr3andki67inhumanbreastcancerpathologyandfiveyearsurvival
AT louisehall mammaglobinavegfr3andki67inhumanbreastcancerpathologyandfiveyearsurvival
AT jamesfrance mammaglobinavegfr3andki67inhumanbreastcancerpathologyandfiveyearsurvival
AT deborahwilson mammaglobinavegfr3andki67inhumanbreastcancerpathologyandfiveyearsurvival
AT pudupalayambhaskar mammaglobinavegfr3andki67inhumanbreastcancerpathologyandfiveyearsurvival